T0	Outcomes 48 82	specific airway resistance changes
T1	Outcomes 440 487	that specific airway resistance changes (ΔsRAW)
T2	Outcomes 592 655	underwent dyspnea evaluation (VAS score) and pulmonary function
T3	Outcomes 740 785	RESULTS Spirographic and ΔsRAW-based criteria
T4	Outcomes 831 844	respectively.
T5	Outcomes 845 850	ΔsRAW
T6	Outcomes 867 910	changes of intrathoracic gas volume (ΔITGV)
T7	Outcomes 920 945	p<0.001), residual volume
T8	Outcomes 961 969	p<0.001)
T9	Outcomes 985 993	p=0.001)
T10	Outcomes 1013 1028	p<0.001), while
T11	Outcomes 1035 1050	correlated only
T12	Outcomes 1104 1112	in terms
T13	Outcomes 1116 1131	ΔITGV (p=0.002)
T14	Outcomes 1137 1146	(p=0.023)
T15	Outcomes 1198 1218	stratified according
T16	Outcomes 1285 1313	bronchodilators, ΔsRAW-based
T17	Outcomes 1324 1355	is preferable to FEV1-FVC-based
T18	Outcomes 1377 1418	closely related to bronchodilator-induced